Lsr2 binding leads to transcription repression (11), influences cell wall synthesis (2), and may play an important role in drug resistance (5)

Lsr2 binding leads to transcription repression (11), influences cell wall synthesis (2), and may play an important role in drug resistance (5). lymphoproliferation were observed in T, L, and HC organizations (analysis of variance [ANOVA],P= 0.000 to 0.015) for those end-to-end peptides except B and for p5 and p7 to p10. Hierarchical acknowledgement between lepromatous and tuberculoid leprosy was mentioned for p8 (P< 0.05) and between the HC and L organizations for p7 to p10, p15, and p16 (P< 0.005 toP< 0.02). Significant lymphoproliferation was observed AMG 900 to peptides A AMG 900 to F and p1 to p9, p11, p12, p15, p16 (P= 0.000 to 0.001) with 40% responding to peptides C and p16 in L individuals. Lepromatous individuals also showed significantly higher levels of a gamma interferon (IFN-) response to peptide C than to additional peptides (P< 0.05). Major histocompatibility complex (MHC) class II bias for peptide acknowledgement was not observed. These studies show that Lsr2 offers multiple T cell epitopes that inducein vitroT cell reactions in the highly infective lepromatous leprosy individuals. == Intro == Though the prevalence of leprosy has been reduced due to multidrug therapy regimens, the incidence continues to be a public health worry in some countries (40). Leprosy is definitely caused by the noncultivableMycobacterium lepraeand is definitely defined by unique clinical-pathological types in humans (29), with the paucibacillary localized tuberculoid forms (borderline tuberculoid/tuberculoid [BT/TT]) having goodin vitroandin vivoT cell functions and low levels of antibodies. In contrast, the multibacillary generalized lepromatous leprosy individuals (borderline leprosy/lepromatous leprosy [BL/LL]) display abundant antibody reactions and T cell unresponsiveness unique to the leprosy bacillus and not to additional antigenically related mycobacteria such asMycobacterium tuberculosis. Moreover, 10 to 15% of stable leprosy individuals undergo inflammatory episodes of types 1 (reversal reactions [RR]) and 2 (erythema nodosum leprosum [ENL]) which are localized to the lesion or produce systemic indications of fever, joint aches and pains, and pores and skin nodules. The inverse relationship between cellular and humoral immunity as well AMG 900 as the dichotomy in the leprosy types has been intensely investigated (21,30). The mechanisms underlying the antigen-specific anergy are not completely understood as it is definitely long-lasting AMG 900 and not reversed by standard therapy. Attempts to improve the host reactions have been made with cross-reacting mycobacteria such asMycobacterium bovisBCG,MycobacteriumW (32,39), andMycobacterium vaccae(38) as well as gamma interferon (IFN-) (15,22). DefiningM. lepraeantigens that would reverse the anergy in the highly infective individuals would provide tools to break the infection cycle in the community as well as aid in early analysis of a disease that has a long incubation period. The annotation of theM. lepraegenome has made it possible to study the part of several immunologically relevant proteins in leprosy (6,7). Synthetic peptides and recombinant products are being progressively used to design diagnostics for early detection of the disease. Both serological and whole-blood T cell assays using specific antigens, proteins, and peptides of the leprosy bacillus have PLA2G4C been carried out (1,18,26,31,35,36). The Lsr2 gene coding for an immunodominant protein was recognized in the 1990s by us (18) as well as others (31) using pooled lepromatous leprosy sera to display the lambda gt11 (42) and a cosmid library. Whereas our clone indicated a 10-kDa Lsr2 protein, Sela et al. (31) cloned the full gene expressing the 15-kDa protein including the AMG 900 5 end missing in our clone. There was a paucity of info within the gene itself asM. lepraeis not cultivable by standard methods. Comparative genomics was not helpful in defining its functions until recently when several other organisms including the medically importantM. tuberculosis,Mycobacterium avium-intracellulare(3,6,7), andMycobacterium smegmatis(2) were shown to have Lsr2 homologues. InM. tuberculosisLsr2 has been characterized to be a unique nucleoid-associated protein, akin to histone-like nucleoid structuring protein (H-NS) (3). It binds AT-rich areas including areas encoding virulence factors such as ESX secretion systems (8), lipid virulence factors, phthiocerol dimycocerosates (PDIM) (5), phenolic glycolipid (PGL) (14), and acidic asparagines or glycine-rich protein (PE/PPE) antigenic family members (11). Lsr2 binding prospects to transcription repression (11), influences cell wall synthesis (2), and may play an important role in drug resistance (5). Lsr2 is definitely upregulated in the presence of iron (41). Lsr2 was shown to be identified by T cells and antibodies of tuberculoid and lepromatous leprosy individuals (18,31,34). Using overlapping synthetic peptides of Lsr2, we showed that ENL individuals experienced sequence-specific antibodies during, as well as prior to, the inflammatory episodes (33). Others showed that T cell lines developed from Norwegian volunteers immunized with heat-killed leprosy bacilli identified HLA-restricted epitopes of Lsr2 (26). The present study.